PDF
DataM
Sleep Apnea Devices Market Report
SKU: MD430

Sleep Apnea Devices Market Size, Share & Forecast 2033

Sleep Apnea Devices Market is segmented By Device Type (Diagnostic Devices, Therapeutic Devices, PAP Devices, Facial Interfaces, Oral Appliances, Adaptive servo-ventilators, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Last Updated: || Author: Rohan Sawant || Reviewed: Akshay Reddy

Market Size & Forecast
Competitive Analysis
Partner Identification
Unmet Needs
Regulatory Compliance
Opportunity Analysis

Stop Guessing and Start Converting. Companies using our Customer Identification Tool are seeing 3x Growth in Qualified Leads.

Report Summary
Table of Contents
List of Tables & Figures

Sleep Apnea Devices Market Size

Sleep Apnea Devices Market size was valued at USD 10,820 million in 2025 and is estimated to reach at a compound annual growth rate (CAGR) of 7.90% over the forecast period 2026-2033.

Sleep apnea is a potentially serious sleep disorder in which breathing repeatedly stops and starts. The goal of sleep apnea treatment is to open the airway so the patient can breathe better at night. Sleep apnea devices can help that happen. Among the most common options are CPAP machines, Facial Interfaces, Adaptive servo-ventilators, and others.

Market Summary

MetricsDetails
Market CAGR7.90%
Segments CoveredBy Device Type, and By Region
Report Insights CoveredCompetitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.
Fastest Growing RegionAsia Pacific
Largest Market Share North America

For More Insights Request free Sample

Sleep Apnea Devices Market Dynamics

North America region holds the largest market share of the global sleep apnea devices market

The global sleep apnea devices market growth is driven by the increasing incidences of sleep apnea, a rise in the aged population, a surge in the occurrence of obesity and hypertension, and rising cognizance among the patient population in emerging economies.

The high cost of CPAP machines is likely to hamper the market growth

For instance, a machine with a heated humidifier costs more than a machine without one. CPAP air filters can cost anywhere from $5 to $30 each, depending on the type of machine. Headgear and mask set generally cost $100 r more. Smaller pieces that need replacing more often, such as mask cushions, range from $20 to $100. The medical visits to multiple locations, the inconvenient and high cost of diagnosis, and therapy create a huge hurdle for patients. These factors will hamper the market in the forecast period.

Sleep Apnea Devices Market Segmentation Analysis

The pulse oximeters segment is expected to hold the largest share in this market segment

The application of pulse oximetry to investigate and diagnose obstructive sleep apnea in adults and children consists of different practices.

Medtronic manufactures a pulse oximeter called Nellcor portable SpO2 patient monitoring system, PM10N. This device is ideal for instant checks and continuous monitoring in various healthcare and also home use settings. Its ergonomic shape and simple design make it intuitive to use and simple to operate. The availability of these types of devices will help with the market growth.

Sleep Apnea Devices Market Key Players

The global sleep apnea devices market is highly competitive with the presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Philips Healthcare, Cadwell Laboratories Inc., Fisher & Paykel Healthcare Limited, Natus Medical Incorporated, ResMed, Nihon Kohden Corporation, Invacare Corporation, keepMED Ltd., Sleep score, BMC Medical CO., Ltd, ImThera Medical Inc., and others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of Sleep Apnea Devices globally. For instance, In February 2021, Oventus Medical launched 02Vent Optima, a customizable oral appliance therapy device that offers an alternative to CPAP therapy in the US through GoPAPfree.

Key Companies to Watch

ResMed

Overview: ResMed develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. The company’s cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Their comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care to set of their choice.

Product Portfolio: It includes products like Acumen 7, Lotus Auto CPAP, Floton, AirSense 11, AirCurve 10 VAuto, AirSense 10 Series.

Acumen 7- It is a sleep diagnostic device  specifically designed for use in the home away from clinical environments. Acumen 7 can record up to 100 hours of relevant physiological data over up to 8 channels.

FAQ’s

  • The market was valued at USD 7,981.8 million in 2021 and is expected to grow at a CAGR of 7.9% during 2026–2033.

  • North America holds the largest share due to advanced healthcare infrastructure, higher awareness, and presence of leading manufacturers.

  • Pulse oximeters are expected to dominate, driven by their wide use in diagnosing and monitoring obstructive sleep apnea

  • Rising sleep apnea prevalence, obesity, aging population, technological advancements, and remote monitoring solutions fuel growth.

  • Major companies include ResMed, Philips Healthcare, Fisher & Paykel, Natus Medical, Nihon Kohden, Invacare, and Oventus Medical.
Related Reports